Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Non-Current Assets (2025 - 2026)

Updated

Global Innovative Platforms' Non-Current Assets came in at $268,652 for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 19.2% from the prior quarter.

Analysis

Global Innovative Platforms (GIPL) Non-Current Assets (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 141.29 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 101.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 87.87 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 14.88 Bn
10 Global Innovative Platforms 24.88 Mn 24.27 Mn - 268,652.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 268,652.00
Mar 31, 2026 225,388.00
Dec 31, 2025 170,435.00
API Access

Global Innovative Platforms Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=GIPL&period=max&api_key=YOUR_API_KEY